Two Sigma Investments, LP Novan, Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.29 - $3.86 $150,752 - $254,107
-65,831 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.95 - $4.41 $354,356 - $529,733
-120,121 Reduced 64.6%
65,831 $259,000
Q4 2021

Feb 14, 2022
BUY
$4.03 - $8.15 $749,386 - $1.52 Million
185,952 New
185,952 $775,000

About Novan, Inc.

NOVN Quotes by TradingView
  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email